Silk Road Medical Inc
NASDAQ:SILK
Balance Sheet
Balance Sheet Decomposition
Silk Road Medical Inc
Silk Road Medical Inc
Balance Sheet
Silk Road Medical Inc
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
33
|
25
|
39
|
70
|
110
|
55
|
20
|
|
| Cash Equivalents |
33
|
25
|
39
|
70
|
110
|
55
|
20
|
|
| Short-Term Investments |
0
|
0
|
52
|
78
|
0
|
158
|
161
|
|
| Total Receivables |
5
|
6
|
9
|
9
|
12
|
18
|
24
|
|
| Accounts Receivables |
5
|
6
|
9
|
9
|
12
|
18
|
24
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
3
|
6
|
10
|
10
|
18
|
19
|
30
|
|
| Other Current Assets |
0
|
1
|
3
|
7
|
3
|
4
|
6
|
|
| Total Current Assets |
42
|
39
|
113
|
173
|
143
|
255
|
241
|
|
| PP&E Net |
1
|
3
|
6
|
6
|
13
|
15
|
15
|
|
| PP&E Gross |
1
|
3
|
6
|
6
|
13
|
15
|
15
|
|
| Accumulated Depreciation |
1
|
1
|
2
|
2
|
3
|
5
|
8
|
|
| Long-Term Investments |
0
|
0
|
18
|
0
|
0
|
0
|
9
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Assets |
43
N/A
|
43
-1%
|
137
+222%
|
179
+30%
|
157
-13%
|
270
+72%
|
265
-2%
|
|
| Liabilities | ||||||||
| Accounts Payable |
2
|
1
|
2
|
3
|
2
|
3
|
6
|
|
| Accrued Liabilities |
3
|
9
|
15
|
17
|
20
|
22
|
24
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
4
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
5
|
11
|
17
|
20
|
26
|
25
|
30
|
|
| Long-Term Debt |
28
|
44
|
45
|
49
|
45
|
75
|
76
|
|
| Other Liabilities |
4
|
17
|
4
|
4
|
7
|
7
|
8
|
|
| Total Liabilities |
36
N/A
|
72
+98%
|
66
-9%
|
72
+10%
|
77
+8%
|
106
+37%
|
114
+8%
|
|
| Equity | ||||||||
| Common Stock |
105
|
105
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
102
|
139
|
192
|
239
|
289
|
344
|
399
|
|
| Additional Paid In Capital |
3
|
5
|
263
|
346
|
368
|
508
|
550
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
7
N/A
|
29
N/A
|
72
N/A
|
108
+50%
|
79
-26%
|
164
+107%
|
151
-8%
|
|
| Total Liabilities & Equity |
43
N/A
|
43
-1%
|
137
+222%
|
179
+30%
|
157
-13%
|
270
+72%
|
265
-2%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
30
|
30
|
31
|
34
|
35
|
38
|
39
|
|